clinicalAssessmentToolId,assessmentName,assessmentType,targetPopulation,diseaseSpecific,numberOfItems,scoringMethod,validatedLanguages,psychometricProperties,administrationTime,availabilityStatus,licensingRequirements,digitalVersion,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
41690aa7-93cc-5c85-8579-9367d647b0b1,cNF-Skindex,questionnaire,adult,Yes,18.0,"7-point Likert scale (0-6), total score 0-108",,,,,,,cNF-Skindex,PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,"The cNF-Skindex is an 18-item questionnaire, including three domains: 'functioning', 'emotions', and 'symptoms'. Each item is scored on a 7-point Likert scale",0.95,Accept,Experimental Usage
8d085b33-a06f-5476-957f-c1d438011c8c,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,questionnaire,adult,Yes,14.0,"0-3 scale per item, maximum score 42",,,,,,,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,,"The Impact of NF1 on Quality of Life (INF1-QOL) questionnaire was developed by a literature search for common terms, focus group (n = 6), semi-structured interviews (n = 21)",0.95,Accept,Development
57f38f1c-aef0-5b8b-a0d6-1150edeeab07,Cirrus HD-OCT,biomarker assay,pediatric,Yes,,,,,,,,,Cirrus HD-OCT,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,"Optical coherence tomography images were obtained using Cirrus HD-OCT device (Cirrus; Carl Zeiss Meditec, Dublin, CA, USA)",0.9,Accept,Experimental Usage
36ba0734-10fe-5733-b761-fed8ba10b043,Teller acuity cards,performance test,pediatric,No,,,,,,,,,Teller acuity cards,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards,0.85,Accept,Experimental Usage
e4d24f91-9ec0-5c15-bccb-11594e0f2602,Cardiff acuity cards,performance test,pediatric,No,,,,,,,,,Cardiff acuity cards,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,In the youngest group VA was assessed with Teller acuity cards or Cardiff acuity cards,0.85,Accept,Experimental Usage
71b9e485-eb19-5321-b8b5-cccda706fe04,Lea cards,performance test,pediatric,No,,,,,,,,,Lea cards,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,while older children were tested with Lea or KM (Konstantin Moutakis) cards,0.85,Accept,Experimental Usage
dd140fcf-1389-5b90-94da-8978ca70bf86,KM (Konstantin Moutakis) cards,performance test,pediatric,No,,,,,,,,,KM (Konstantin Moutakis) cards,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,while older children were tested with Lea or KM (Konstantin Moutakis) cards,0.85,Accept,Experimental Usage
cbb461af-25d6-591f-864c-b4808d7d6989,Humphrey Field Analyzer perimetry,performance test,pediatric,No,,,,,,,,,Humphrey Field Analyzer perimetry,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,Visual fields were assessed with the Humphrey Field Analyzer perimetry as previously described,0.9,Accept,Experimental Usage
814144de-175f-512e-9299-125ece9cc7e4,World Health Organization Categories of Childhood VI scale,scale,pediatric,No,,,,,,,,,World Health Organization Categories of Childhood VI scale,PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,In children ≥4 years of age VA at initial visit was compared with World Health Organization Categories of Childhood VI scale for reference,0.9,Accept,Experimental Usage
5b689dd7-5fc9-567b-9415-ba38fc1d245c,Likert scale questionnaire,questionnaire,clinician-rated,Yes,25.0,Likert 1-5,,,,,,,Likert scale questionnaire,PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,A Likert scale questionnaire was used to survey clinicians' levels of agreement with 25 statements related to 2D and 3D tumor analyses.,0.85,Accept,Experimental Usage
bd963f64-921c-550d-9232-3c624b167c15,BoN (Burden of NF1) questionnaire,questionnaire,adult,Yes,15.0,"6-point Likert scale: never (0), rarely (1), sometimes (2), often (3), very often (4), constantly (5)",,,,,,,BoN (Burden of NF1) questionnaire,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"This study sought to develop a self-administered questionnaire in French to assess the burden of NF1 (BoN), then translate and linguistically and cross-culturally validate it",0.95,Accept,Development
d3b1dfbf-71ee-5e64-aa45-833969852d65,Dermatology Life Quality Index (DLQI),questionnaire,adult,No,,"0–30 scale, with high scores reflecting poor QoL",,,,,,,Dermatology Life Quality Index (DLQI),PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,all participants were asked to complete three previously validated self-administered questionnaires: the Dermatology Life Quality Index [DLQI] questionnaire,0.9,Accept,Experimental Usage
cd5ce5c7-6228-5faf-9949-4ca03c7e99c1,SF12,questionnaire,adult,No,12.0,"composite scores, higher score indicates better physical and mental quality of life",,,,,,,SF12,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"The SF12 is a short version of the SF-36, namely a generic instrument to measure population health with a physical composite score and mental composite score calculated based on 12 questions",0.9,Accept,Experimental Usage
1b6e2a2a-af7b-595c-ac77-fca8a5b13e5d,PlexiQoL,questionnaire,adult,Yes,18.0,True/Not True response options,,,,,,,PlexiQoL,PMID:33085177 | PMID:38499890,10.1002/mgg3.1530 | 10.1186/s41687-024-00714-y,"The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. | The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,The PlexiQoL is the first disease-specific PRO assessing the ability of adults with NF-1 associated pNFs to meet their basic human needs. | The PlexiQoL questionnaire is a disease-specific QoL measure for adults with NF1-associated plexiform neurofibromas...consists of 18 items with a dichotomous response option,0.95,Accept,Development
